Literature DB >> 34939392

Efficacy of needling acupoints of Guanyuan (CV4), Sanyinjiao (SP6), Zusanli (ST36), Pishu (BL20), Shenshu (BL23), Zigong (EX-CA1) on expression of p38 mitogen-activated protein kinase in ovarian tissue in rats with premature ovarian failure induced by cyclophosphamide.

Sheng-Chun Wang1, Yi-Ming Jiang2, Li-Rong Qiu2, Meng Su2.   

Abstract

OBJECTIVE: To investigate the efficacy of needling acupoins of Guanyuan (CV4), Sanyinjiao (SP6), Zusanli (ST36), Pishu (BL20), Shenshu (BL23), Zigong (EX-CA1) on the expression of p38 mitogen-activated protein kinase (p38MAPK) in ovarian tissue in rats with premature ovarian failure induced by cyclophosphamide, and to study the underlying mechanism.
METHODS: Forty specific pathogen free female Sprague-Dawley rats were randomly divided into the blank group, the model group, the acupuncture group, the Western Medicine group and the Western Medicine combined with acupuncture group. Except the blank group, the rest of the rats were given with cyclophosphamide for 14 d to establish premature ovarian failure model. No intervention was conducted in the blank group and model group; the acupuncture group was given with acupuncture daily; the Western Medicine group was given with estradiol valerate (0.09 mg/kg) by intragastrical gavage daily; the combination group was given with acupuncture combined with estradiol valerate (0.09 mg/kg) daily. Each group was intervened in continuously for 14 d. After the last treatment, the levels of estradiol (E2), follicle stimulating hormone (FSH) and luteinizing hormone (LH) were detected by enzyme-linked immunosorbent assay, then the ovarian tissue was dissected. Western blot was used to detect the expression of p38MAPK protein.
RESULTS: Compared with the blank group, E2 in the serum of rats in the model group was significantly decreased (P < 0.05), FSH and LH were significantly increased (P < 0.05), and the expression of p38MAPK protein in the ovarian tissue of the rats was significantly increased (P < 0.05). Compared with the model group, E2 in the serum of the acupuncture group, Western Medicine group and the combination group were significantly increased (P < 0.05), FSH and LH levels were significantly decreased (P < 0.05), and the expression of p38MAPK protein in the ovarian tissue of the rats was significantly decreased (P < 0.05). However, there was no statistically significant difference between the Western Medicine group and the acupuncture group (P > 0.05).
CONCLUSIONS: Acupuncture has the same effect as estrogen in interfering POF caused by cyclophosphamide, and its mechanism may be related to inhibiting the expression of p38MAPK protein in ovarian tissue and affecting the activation of p38MAPK signaling pathway.

Entities:  

Keywords:  Acupuncture; Premature ovarian insufficiency; Signal transduction; p38 mitogen-activated protein kinase

Mesh:

Substances:

Year:  2021        PMID: 34939392     DOI: 10.19852/j.cnki.jtcm.2021.06.012

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  3 in total

1.  Effect of Comprehensive Care Based on Appropriate Chinese Medicine Techniques on Urinary Retention and Bladder Function Recovery after Total Hysterectomy in Patients with Cervical Cancer.

Authors:  Qing Lu; LiangHong Wu; LiYing Qi; Ping Tie; Zhihong Guan
Journal:  Comput Math Methods Med       Date:  2022-06-30       Impact factor: 2.809

2.  Electro-Acupuncture Regulates Metabolic Disorders of the Liver and Kidney in Premature Ovarian Failure Mice.

Authors:  Min Chen; Qi-da He; Jing-Jing Guo; Qi-Biao Wu; Qi Zhang; Yuen-Ming Yau; Yu-Feng Xie; Zi-Yi Guo; Zi-Yan Tong; Zong-Bao Yang; Lu Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-25       Impact factor: 6.055

3.  Effects of Electroacupuncture on the Gut Microbiome in Cisplatin-Induced Premature Ovarian Failure Mice.

Authors:  Qi-da He; Jing-Jing Guo; Qi Zhang; Yuen-Ming Yau; Yue Yu; Zheng-Hong Zhong; Zi-Yan Tong; Zong-Bao Yang; Min Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-14       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.